Roche Takes Option To Buy Lonza Plant | September 7, 2009 Issue - Vol. 87 Issue 36 | Chemical & Engineering News
Volume 87 Issue 36 | p. 29 | Concentrates
Issue Date: September 7, 2009

Roche Takes Option To Buy Lonza Plant

Department: Business
Keywords: Roche, Lonza, biologics, Singapore

Roche has exercised an option to buy Lonza’s cell culture biologic facility in Singapore. The price is $290 million plus milestone payments of $70 million. Roche says the 80,000-L plant will produce bevacizumab, the active ingredient in the cancer drug Avastin. The sale was anticipated by a 2006 deal between Lonza and Genentech, now part of Roche, under which Lonza bought a Genentech plant in Spain and agreed to eventually sell the Singapore plant to Genentech. Lonza plans to open another 80,000-L cell culture plant in Singapore by 2011.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment